Research Topics
| Edward RyanSummaryAffiliation: Massachusetts General Hospital Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Transcutaneous immunization with a Vibrio cholerae O1 Ogawa synthetic hexasaccharide conjugate following oral whole-cell cholera vaccination boosts vibriocidal responses and induces protective immunity in miceA A Tarique
Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA
Clin Vaccine Immunol 19:594-602. 2012..Our results suggest that transcutaneous and subcutaneous boosting with a neoglycoconjugate following oral cholera vaccination may be an effective strategy to prolong protective immune responses against V. cholerae...
Cholera vaccinesE T Ryan
Tropical and Geographic Medicine Center, Travelers Advice and Immunization Center, Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA
Clin Infect Dis 31:561-5. 2000..cholerae for at least 6 months. No commercially available cholera vaccine protects against disease caused by V. cholerae serogroup O139. New cholera vaccines are being developed...
Transcutaneous immunization with Clostridium difficile toxoid A induces systemic and mucosal immune responses and toxin A-neutralizing antibodies in miceChandrabali Ghose
Division of Infectious Diseases, Massachusetts General Hospital, Jackson 504, 55 Fruit Street, Boston, MA 02114, USA
Infect Immun 75:2826-32. 2007..Our results suggest that transcutaneous immunization with CDA toxoid may be a feasible immunization strategy against C. difficile, an important cause of morbidity and mortality against which current preventative strategies are failing...
Live attenuated oral cholera vaccinesEdward T Ryan
Massachusetts General Hospital Tropical and Geographic Medicine Center, Division of Infectious Diseases, Jackson 504 55 Fruit Street, Boston, MA 02114, USA
Expert Rev Vaccines 5:483-94. 2006..cholerae O139, including CVD 112 and Bengal-15. Live, orally administered, attenuated cholera vaccines are in various stages of development and evaluation...
Illness after international travelEdward T Ryan
Tropical and Geographic Medicine Center, Division of Infectious Diseases, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
N Engl J Med 347:505-16. 2002
Local production of anti-vibrio cholerae mucosal antibody in reproductive tract tissues after choleraE T Ryan
Tropical and Geographic Medicine Center, Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02114, USA
J Infect Dis 184:643-7. 2001..The ability to generate specific mucosal immune responses in reproductive tract tissues after intestinal presentation of antigen could facilitate development of vaccines effective against reproductive tract pathogens...
Transcutaneous immunization with toxin-coregulated pilin A induces protective immunity against Vibrio cholerae O1 El Tor challenge in miceJulianne E Rollenhagen
Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
Infect Immun 74:5834-9. 2006..001). Our results suggest that transcutaneous immunization with TcpA and an immunoadjuvant induces protective anti-TcpA immune responses. Anti-TcpA responses may contribute to an optimal cholera vaccine...
Transcutaneous immunization with a synthetic hexasaccharide-protein conjugate induces anti-Vibrio cholerae lipopolysaccharide responses in miceJulianne E Rollenhagen
Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02114, USA
Vaccine 27:4917-22. 2009..Our results suggest that transcutaneously applied synthetic V. cholerae neoglycoconjugate is safe and immunogenic, but predominantly induces systemic LPS responses of the IgG isotype...
Comparison of mucosal and systemic humoral immune responses after transcutaneous and oral immunization strategiesManohar John
Tropical and Geographic Medicine Center, Division of Infectious Diseases, Jackson 504, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA
Vaccine 20:2720-6. 2002..Our results suggest that combination oral and transcutaneous immunization strategies may most prominently induce both mucosal and systemic humoral responses...
Use of in vivo-induced antigen technology (IVIAT) to identify genes uniquely expressed during human infection with Vibrio choleraeLong Hang
Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02114, USA
Proc Natl Acad Sci U S A 100:8508-13. 2003..cholerae O1. In vivo-induced antigen technology provides a simple method for identifying microbial proteins expressed during human infection, but not during in vitro growth...
Complexity of rice-water stool from patients with Vibrio cholerae plays a role in the transmission of infectious diarrheaEric J Nelson
Howard Hughes Medical Institute and Department of Molecular Biology and Microbiology, Tufts University School of Medicine, 136 Harrison Avenue, Boston, MA 02111, USA
Proc Natl Acad Sci U S A 104:19091-6. 2007..cholerae. If lytic phage are present, viable counts of V. cholerae drop, stools become DF(-), other microorganisms bloom, and cholera transmission is reduced...
Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in BangladeshJason B Harris
Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA
PLoS Negl Trop Dis 2:e221. 2008..Despite recent progress in understanding the molecular basis of Vibrio cholerae pathogenesis, there is relatively little knowledge of the factors that determine the variability in human susceptibility to V. cholerae infection...
Proteomic analysis of Vibrio cholerae in human stoolRegina C LaRocque
Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
Infect Immun 76:4145-51. 2008..We identified a number of these in vivo expressed proteins as immunogenic during human infection. To our knowledge, this is the first characterization of the proteome of a pathogenic bacteria recovered from a natural host...
Immunologic responses to Vibrio cholerae in patients co-infected with intestinal parasites in BangladeshJason B Harris
Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA
PLoS Negl Trop Dis 3:e403. 2009..However, the immunomodulatory effects of concomitant intestinal parasitic infection in cholera patients have not been systematically evaluated...
Identification of in vivo-induced bacterial protein antigens during human infection with Salmonella enterica serovar TyphiJason B Harris
Division of Infectious Diseases, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA
Infect Immun 74:5161-8. 2006..Serovar Typhi antigens identified by IVIAT warrant further evaluation for their contributions to pathogenesis, and they may have diagnostic, therapeutic, or preventive uses...
Postgenomic approaches to cholera vaccine developmentRegina C LaRocque
Division of Infectious Diseases, Massachusetts General Hospital, GRJ 504, 55 Fruit Street, Boston, MA 02114, USA
Expert Rev Vaccines 5:337-46. 2006..This work holds promise for the identification of bacterial targets of protective human immune responses and may contribute to the development of a new generation of cholera vaccines...
Application of in vivo induced antigen technology (IVIAT) to Bacillus anthracisSean M Rollins
Massachusetts General Hospital, Boston, Massachusetts, United States of America
PLoS ONE 3:e1824. 2008..anthracis infection. Identification of L-alanine amidases with B. anthracis specificity may suggest new potential therapeutic targets...
Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicityJason B Harris
Division of Infectious Diseases, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA
Infect Immun 73:7422-7. 2005..Based on this epidemiologic evidence, we propose a hypothesis for understanding the association between blood group O and the risk of infection with V. cholerae O1 and O139 as well as the risk of developing severe symptoms once infected...
Comparative proteomic analysis of the PhoP regulon in Salmonella enterica serovar Typhi versus TyphimuriumRichelle C Charles
Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA
PLoS ONE 4:e6994. 2009..The PhoP regulon is a well studied two component (PhoP/Q) coordinately regulated network of genes whose expression is required for intracellular survival of S. enterica...
Pre-travel health advice-seeking behavior among US international travelers departing from Boston Logan International AirportRegina C LaRocque
Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02114, USA
J Travel Med 17:387-91. 2010..Despite this, data about sources of health information used by international travelers are limited...
Characterization of anti-Salmonella enterica serotype Typhi antibody responses in bacteremic Bangladeshi patients by an immunoaffinity proteomics-based technologyRichelle C Charles
Division of Infectious Diseases, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA
Clin Vaccine Immunol 17:1188-95. 2010..Typhi-infected patients and detected anti-HlyE responses at the time of clinical presentation in patients but not in controls. These findings could assist in the development of improved diagnostic assays...
Prevention of infection in adult travelers after solid organ transplantationCamille Nelson Kotton
Transplant Infectious Disease and Compromised Host Program, Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA
Am J Transplant 5:8-14. 2005..This review considers risks of international travel to adult solid organ transplant recipients and the use of vaccines and prophylactic agents in this population...
Transcriptional profiling of Vibrio cholerae recovered directly from patient specimens during early and late stages of human infectionRegina C LaRocque
Division of Infectious Diseases, Gray Jackson 504, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA
Infect Immun 73:4488-93. 2005..These findings provide a more detailed assessment of the transcriptome of V. cholerae in the human host than previous studies of organisms in stool alone and have implications for cholera control and the design of improved vaccines...
Clinical outcomes in household contacts of patients with cholera in BangladeshAna A Weil
International Centre for Diarrhoeal Disease Research Dhaka, Bangladesh
Clin Infect Dis 49:1473-9. 2009..cholerae infection and associated clinical symptoms in household contacts of patients with cholera and to identify risk factors for development of severe dehydration in this cohort...
Vaccination strategiesLouise C Ivers
Tropical and Geographic Medicine Center, Division of Infectious Diseases, Massachusetts General Hospital, 55 Fruit Street, Jackson 504, Boston, MA 02114, USA
Clin Occup Environ Med 4:27-43. 2004..When considering work-force productivity, work-force infectivity, and the common good, careful consideration should be given to establishing at least a basic immunization program for in-country nationals and their dependents...
Medical problems in the returning expatriateNatasha Hochberg
Department of Internal Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA
Clin Occup Environ Med 4:205-19. 2004..Many infections associated with long-term overseas deployment may include dermatologic manifestations, including filariasis and leishmaniasis...
Diarrheal epidemics in Dhaka, Bangladesh, during three consecutive floods: 1988, 1998, and 2004Brian S Schwartz
Division of Infectious Diseases, Massachusetts General Hospital, Boston, USA
Am J Trop Med Hyg 74:1067-73. 2006..Our findings suggest that cholera is the predominant cause of flood-associated diarrheal epidemics in Dhaka, but that other organisms spread by the fecal-oral route also contribute...
Infectious diseases of severe weather-related and flood-related natural disastersLouise C Ivers
Division of Social Medicine and Health Inequalities, Brigham and Women's Hospital, Boston, Massachusetts, USA
Curr Opin Infect Dis 19:408-14. 2006..SUMMARY: Weather or flood-related natural disasters may be associated with an increased risk of soft tissue, respiratory, diarrheal, and vector-borne infectious diseases among survivors and responders...
Case records of the Massachusetts General Hospital. Case 39-2005. A 63-year-old woman with a positive serologic test for syphilis and persistent eosinophiliaEdward T Ryan
Tropical and Geographic Medicine Center, Massachusetts General Hospital, USA
N Engl J Med 353:2697-705. 2005
Yersinia pestis and the plagueSarah E Rollins
Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
Am J Clin Pathol 119:S78-85. 2003..Advances also have been made in rapid diagnosis, the understanding of immune responses during plague, and vaccine development...
Cholera toxin-specific memory B cell responses are induced in patients with dehydrating diarrhea caused by Vibrio cholerae O1Channa R Jayasekera
International Centre for Diarrhoeal Disease Research, Bangladesh
J Infect Dis 198:1055-61. 2008..The presence of antigen-specific memory B cells may therefore be a more direct measure of protection than serum antibody responses...
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 20-2002. A 37-year-old man with fever, hepatosplenomegaly, and a cutaneous foot lesion after a trip to AfricaAnne C Moore
N Engl J Med 346:2069-76. 2002
Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban BangladeshDebasish Saha
International Centre for Diarrheal Disease Research, Bangladesh
J Infect Dis 189:2318-22. 2004..No association between baseline vibriocidal titer and protection from V. cholerae O139 infection was found. Our findings suggest that the vibriocidal antibody is an incomplete predictor of protection from V. cholerae infection...
Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markersFirdausi Qadri
International Centre for Diarrhoeal Disease Research, Bangladesh, Centre for Health and Population Research, Mohakhali, Dhaka 1212, Bangladesh
Infect Immun 71:4808-14. 2003....
The major subunit of the toxin-coregulated pilus TcpA induces mucosal and systemic immunoglobulin A immune responses in patients with cholera caused by Vibrio cholerae O1 and O139Muhammad Asaduzzaman
International Centre for Diarrhoeal Disease Research, Mohakhali, Dhaka, Bangladesh
Infect Immun 72:4448-54. 2004..These results demonstrate that TcpA is immunogenic following natural V. cholerae infection and suggest that immune responses to this antigen should be evaluated for potential protection against subsequent life-threatening illness...
Cryptosporidiosis among Bangladeshi children with diarrhea: a prospective, matched, case-control study of clinical features, epidemiology and systemic antibody responsesWasif A Khan
Clinical Sciences Division, Centre for Health and Population Research, International Center for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh, GPO Box 128, Dhaka 1000, Bangladesh
Am J Trop Med Hyg 71:412-9. 2004..However, there was a significant difference between children with acute and persistent diarrhea in changes in both IgA and IgM levels, with persistent diarrhea being associated with a decrease in levels of both antibodies...
Reduction in capsular content and enhanced bacterial susceptibility to serum killing of Vibrio cholerae O139 associated with the 2002 cholera epidemic in BangladeshFirdausi Qadri
International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka
Infect Immun 73:6577-83. 2005..cholerae O139. Consequently, this assay may be useful in studies of both O139-infected patients and recipients of O139 vaccines...
Hyperinfectivity of human-passaged Vibrio cholerae can be modeled by growth in the infant mouseAshfaqul Alam
International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh
Infect Immun 73:6674-9. 2005..cholerae as well as the contribution of three type IV pili to the phenotype...
Transformation of the developing world: socioeconomic matrixDennis Carroll
US Agency for International Development, Wsahington, DC, USA
Emerg Infect Dis 10:2049. 2004
Low risk of hemolytic uremic syndrome after early effective antimicrobial therapy for Shigella dysenteriae type 1 infection in BangladeshMichael L Bennish
Africa Centre for Health and Population Studies, Mtubatuba, South Africa
Clin Infect Dis 42:356-62. 2006..001-0.022). CONCLUSION: In persons infected with S. dysenteriae type 1, early administration of effective antibiotics is associated with decreased Stx concentrations in stool and a low risk of developing HUS...
Management of travellers' diarrhoeaDavid R Hill
National Travel Health Network and Centre, and London School of Hygiene and Tropical Medicine, Hospital for Tropical Diseases, London WC1E 6JB
BMJ 337:a1746. 2008
The practice of travel medicine: guidelines by the Infectious Diseases Society of AmericaDavid R Hill
National Travel Health Network and Centre, London School of Hygiene and Tropical Medicine, London, WC1E 6AU, England
Clin Infect Dis 43:1499-539. 2006
Bacteremia, fever, and splenomegaly caused by a newly recognized bartonella speciesMarina E Eremeeva
Centers for Disease Control and Prevention, Atlanta, USA
N Engl J Med 356:2381-7. 2007..We characterized this isolate, including its ability to cause fever and sustained bacteremia in a rhesus macaque. The route of infection and burden of human disease associated with this newly described pathogen are currently unknown...
Research Grants
- Global TravEpiNet: Global Travelers' Health National Research Center ConsortiumEdward Ryan; Fiscal Year: 2007..We would use data generated through this network in an attempt to estimate national vaccine coverage rates (and other preventative strategies) among international travelers. ..
- Transcutaneous and oral-transcutaneous cholera immunization with TcpA and Peru15Edward Ryan; Fiscal Year: 2007....
- High throughput proteomic analysis of Salmonella entericaEdward Ryan; Fiscal Year: 2007....
- Mucosal Immunity to Antigens Expressed by V.choleraeEdward Ryan; Fiscal Year: 2006..difficile toxin A is injected into ligated ileal loops of vaccinated and control animals. ..
- Application of IVIAT to Bacillus anthracisEdward Ryan; Fiscal Year: 2004..IVIAT is an established protocol in our laboratory, and this preliminary collaborative study should lay a foundation for subsequent analysis of identified B. anthracis genes and their products. ..
